SureGene Receives IRS Funds, SBIR Matching Grant to Advance PGx of Antipsychotic Drugs | GenomeWeb

SureGene has received a $244,500 Therapeutic Discovery Project Tax Credit from the Department of Health and Human Services and the Internal Revenue Service to support the development of a molecular diagnostic that aims to help doctors administer antipsychotic medications to those most likely to benefit.

The company announced this week that it received the grant under the Qualifying Therapeutic Discovery Project, which was created by the Patient Protection and Affordable Care Act of 2010.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.